Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Prostatic Neoplasms 3Lung Neoplasms 2Breast Neoplasms 2Vitamin D Deficiency 1Tobacco Use Disorder 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Pneumonia 1Obesity 1Neoplasms 1Mouth Neoplasms 1Melanoma 1Leukemia 1Crohn Disease 1Castration-resistant Prostate Cancer 1Carcinoma, Non-Small-Cell Lung 1Arthritis, Rheumatoid 1Alopecia 1

Interventions

Carboplatin 235Pemetrexed 214Paclitaxel 160Cisplatin 150pembrolizumab 145Erlotinib Hydrochloride 141Docetaxel 133Gemcitabine 94Bevacizumab 85Nivolumab 72Radiotherapy 62atezolizumab 41Radiosurgery 37Afatinib 37osimertinib 35130-nm albumin-bound paclitaxel 35Cetuximab 34durvalumab 33Ipilimumab 32Gefitinib 31Albumin-Bound Paclitaxel 29Vinorelbine 23Taxes 22Etoposide 20Crizotinib 19Radiation 17Sorafenib 16Cyclophosphamide 16Dexamethasone 15Magnetic Resonance Spectroscopy 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Carcinoma, Non-Small-Cell Lung × Calcitriol × Clear all
NCT00794547 2017-12-12

Phase I/II Calcitriol in Lung Cancer

University of Michigan Rogel Cancer Center

Phase 1/2 Terminated
34 enrolled 12 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡